Large‐scale quantitative clinical proteomics by label‐free liquid chromatography and mass spectrometry
Ayako Negishi(Chemotherapy Foundation), Tesshi Yamada(Okazaki City Hospital), Tomohiro Sakuma, Hideya Kuwabara, Hidenori Kato(University of Electro-Communications), Reiko Satow(Tokyo University of Pharmacy and Life Sciences), Masaya Ono, Yasushi Handa(National Hospital Organization Hokkaido Medical Center), Kohki Yamashita(National Hospital Organization Hokkaido Medical Center), Ken Omura(Ebina General Hospital), Miki Shitashige(Chemotherapy Foundation), Setsuo Hirohashi(National Cancer Research Institute), Kazufumi Honda(Nippon Medical School Hospital)
Cited by 43
Related Papers
Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer
|Cancer Research|2008|618
Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
|Gastroenterology|2008|471
Pathology of small hepatocellular carcinoma. A proposal for a new gross classification
|Cancer|1987|360
Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma
|International Journal of Clinical Oncology|2014|263